


TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporation

Neuroprotection Biotech Bionure Reports Successful Phase 1 Study for Lead Candidate BN201

PDC*line Pharma obtains authorization to launch phase I/II trial of its cancer vaccine (PDC*lung01) in non-small cell lung cancer

Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target

CDMO Yposkesi appoints new Director of Viral Vector Manufacturing Operations

TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best in class quality check, to cell and gene therapy leader Imagine Institute

XenTech signs strategic collaboration agreement with Gustave Roussy Cancer Center
Alizé Pharma 3 to present data from its AZP-3404 program at ENDO 2019
